Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir dose reduction regimens in chronic hepatitis B with tenofovir-induced renal dysfunction
TCTR20180207001Phase 3Recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gastroenterological Association of Thailand. Started Jan 2018; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20180207001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180207001.